Skip to main content
SpringerLink
Log in

Pharmacoeconomic Assessment of Antiallergic Drugs by Comparing Serum Immunoglobulin E Level as a Diagnostic and Monitoring Indicator of Allergic Rhinitis in Rural Population of India

  • Original Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

Allergic rhinitis (AR) is a chronic inflammatory disease induced by IgE mediated reaction and identified clinically by presence of nasal discharge, sneezing, itching and nasal congestion. Aim of this study was to determine Serum IgE level which is an important indicator of AR. To analyse the diagnostic significance of serum IgE level and their pharmacoeconomic status in the management of AR with commonly used antihistaminic. Estimation of serum IgE can serve as a simple and reliable investigative tool in the diagnostic and management of AR. Fifty two adult patient with history of allergic rhinitis were randomly divided into four study groups and administered either Cetirizine, Levocetirizine, Loratidine or Fexofenadine respectively for one week. Blood samples were analysed to determine serum IgE level and the results were subjected to statistical analysis. The mean value and standard deviation were obtained and tabulated using paired t test. A total 52 patient were divided into four group, 13 in each group of age between 18 and 65 years (mean age 33.73 ± 10.23 years); 48.08% females and 51.92% male were randomized. Mean compliance with treatment was 100% for all study groups. The mean serum IgE level was significantly reduced in Levocetirizine as compared to Cetirizine, Loratidine and Fexofenadine groups. Levocetirizine controls the symptoms of AR better as compared to Cetirizine, Loratidine and Fexofenadine and is a better choice due to its cost effectiveness, tolerability and safety profile.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Varlato G, Corsico A, Villani S (2003) Is the prevalence of adult asthma and allergic rhinitis still increasing? Results of an Italian study. J Allergy Clin Immunol 111(6):1232–1238

    Article  Google Scholar 

  2. Dykewicz MS, Finman S (1998) Executive summary of joint task force practice parameters on diagnosis and management of rhinitis. Ann Allergy Asthma Immunol 81:463–468

    Article  CAS  PubMed  Google Scholar 

  3. Bauchau V, Durham SR (2005) Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 60:350–353

    Article  CAS  PubMed  Google Scholar 

  4. Bousquet J, Khaltaev N, Cruz AA (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization). Allergy 63(suppl.86):8–160

    Article  PubMed  Google Scholar 

  5. Baraniuk JN (1997) Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 99(2):763–772

    Article  Google Scholar 

  6. Ishizaka K, Ishizaka T, Hornbrook MM (1996) Physiochemical properties of reaginic antibody. Correlation with reaginic activity with gamma-E-globulin antibody. J Immunol 97:840–853

    Article  Google Scholar 

  7. Palomares O, Alkdis M, Martin- Fontecha M, Alkdis CA (2017) Mechanism of immune regulation in allergic disease: the role of regulatory T and B cells. Immunol Rev 278:219–236

    Article  CAS  PubMed  Google Scholar 

  8. Abramson J, Petch I (2007) Regulkation of mast cell response to the type I Fcε receptor. Immunol Rev 217:231–235

    Article  CAS  PubMed  Google Scholar 

  9. Corsico AG et al (2017) Allergen specific immunoglobulin E and allergic rhinitis severity. Allergy Rhinol 8(1):e1–e4

    Google Scholar 

  10. Thwaits R, Townsend JR (1998) Pharmaco-economics in the new millennium: a pharmaceutical industry perspective. Pharmacoeconomics 13(2):175–180

    Article  Google Scholar 

  11. Plebani M, Bernardi D, Basso D, Faggian D et al (1998) Measurement of specific immunoglobulin E: intermethod comparison and standardization. Clinchem 9:44

    Google Scholar 

  12. Homerger HA, Yuninger JW (1983) Laboratory testing in the diagnosis and management of allergic disease. Clin Lab 2:351–388

    Google Scholar 

  13. Lopert R, Lang DL (2003) Use of pharmacoeconomic in prescribing research. Part 3: cost effectiveness analysis—a technique for decision making at the margin. J Clin Pharm Ther 28:243–249

    Article  CAS  PubMed  Google Scholar 

  14. Moseges R, Konig V, Koberlein J (2013) The effectiveness of modern antihistaminics for the treatment of allergic rhinitis—an IPD meta-analysis of 140853 pateints. Allergol Int 62(2):215–222

    Article  Google Scholar 

  15. Ciprandi G, Cirillo I, Vizzaccaro A, Tosca MA (2004) Levoceririze improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study. Clin exp allergy 34(6):958–964

    Article  CAS  PubMed  Google Scholar 

  16. Horak F, Zieglmayer PU et al (2005) Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration. Br J Clin Pharmacol 60(1):31–34

    Article  Google Scholar 

  17. Stubner P, Zieglmayer HF (2004) A direct comparison of the efficacy of antihistaminics in SAR and PAR: the Vienna Challenge Chamber (VCC). Curr Med Res Opin 20(6):891–902

    Article  CAS  PubMed  Google Scholar 

  18. Dubaaske LM, Seal B, Brown MC (2008) Pharamacoeconomics of Levocetirizine in allergic rhinitis and chronic idiopathic urticaria: consideration for the USA. Expert Rev Pharmacoecon Outcomes Res 8(3):233–241

    Article  Google Scholar 

  19. Rogkakou A et al (2011) Persistent allergic rhinitis and the XPERT study. World Allergy Organ J 4(3):S32

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Authors would like to thank department of ENT for allowing them to conduct study, also would like to thank Mrs. Raje Swati, Assistant Professor, Department of Community Medicine for data analysis and valuable guidance during the development of this manuscript and provide valuable input for statistical and pharmacoeconomic analysis.

Funding

This study was not financially supported from external sources.

Author information

Authors and Affiliations

  1. Department of Pharmacology, MIMER Medical College, Talegaon Dabhade, India

    Ganesh Satyadeo Pentewar

  2. Sushrut ENT Hospital and Dr. Khan’s ENT Research Center, Talegaon Dabhade, India

    Sapna Ramkrishna Parab

Authors
  1. Ganesh Satyadeo Pentewar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sapna Ramkrishna Parab
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sapna Ramkrishna Parab.

Ethics declarations

Conflict of interest

None declared.

Ethical Approval

The study was approved by the Institutional Ethical Committee.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pentewar, G.S., Parab, S.R. Pharmacoeconomic Assessment of Antiallergic Drugs by Comparing Serum Immunoglobulin E Level as a Diagnostic and Monitoring Indicator of Allergic Rhinitis in Rural Population of India. Indian J Otolaryngol Head Neck Surg 75 (Suppl 1), 928–933 (2023). https://doi.org/10.1007/s12070-023-03488-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-023-03488-9

Keywords

Search

Navigation